The SG Lab and Nelson Labs Europe are able to supply the most advanced and complete systems for the chemical characterisation of primary packaging, in order to detect and mitigate the risk of chemical interaction with pharmaceuticals.
Chemical feedback from the container closure system improves the possibility of performing a risk mitigation process (preliminary assessment) for the container closure’s potential interaction with a pharmaceutical, consisting in:
In January 2017, SG Lab signed an agreement with Nelson Labs based on the mutual exchange of state of the art knowledge, expertise and capabilities.
Nelson Labs is an independent, privately owned Contract Research Organisation, specialized in providing premium Extractable & Leachable Services to the Pharmaceutical Industry.
This strategic partnership enables SG Lab and Nelson Labs to leverage their collective expertise in premium container/closure development for small volume parenterals, the in-depth scientific knowledge and supporting cutting-edge analytical technologies.
Creating and offering a suite of world-class supporting services which would allow Pharmaceutical and Biopharmaceutical companies to move much faster in the qualification and acceptance process of Ompi’s container/closure systems, is the main object of this collaboration.